Acorah Software Products - Accounts Production 19.4.351 false true false 1 February 2025 31 January 2026 31 January 2026 10474227 Mr Mitul Patel Mr Kanwardeep Dhanoa - DO NOT USE iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10474227 2025-01-31 10474227 2026-01-31 10474227 2025-02-01 2026-01-31 10474227 frs-core:ShareCapital 2026-01-31 10474227 frs-core:RetainedEarningsAccumulatedLosses 2026-01-31 10474227 frs-bus:PrivateLimitedCompanyLtd 2025-02-01 2026-01-31 10474227 frs-bus:FilletedAccounts 2025-02-01 2026-01-31 10474227 frs-bus:SmallEntities 2025-02-01 2026-01-31 10474227 frs-bus:AuditExempt-NoAccountantsReport 2025-02-01 2026-01-31 10474227 frs-bus:SmallCompaniesRegimeForAccounts 2025-02-01 2026-01-31 10474227 frs-bus:Director1 2025-02-01 2026-01-31 10474227 frs-bus:Director2 2025-02-01 2026-01-31 10474227 frs-countries:EnglandWales 2025-02-01 2026-01-31
Registered number: 10474227
Pharmaco Partnership Limited
Financial Statements
For The Year Ended 31 January 2026
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: 10474227
2026
Notes £ £
FIXED ASSETS
Investment Properties 4 1,778,941
1,778,941
Creditors: Amounts Falling Due Within One Year 5 (1,023,629 )
NET CURRENT ASSETS (LIABILITIES) (1,023,629 )
TOTAL ASSETS LESS CURRENT LIABILITIES 755,312
NET ASSETS 755,312
CAPITAL AND RESERVES
Called up share capital 6 1,000
Profit and Loss Account 754,312
SHAREHOLDERS' FUNDS 755,312
For the year ending 31 January 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Mr Kanwardeep Dhanoa - DO NOT USE
Director
1 October 2026
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Pharmaco Partnership Limited is a private company, limited by shares, incorporated in England & Wales, registered number 10474227 . The registered office is C/O Hunts Pharmacy, 205 Plumstead Road, Norwich, Norfolk, NR1 4AB.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Investment Properties
All investment properties are carried at fair value determined annually and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided for. Changes in fair value are recognised in the profit and loss account.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 2
2
4. Investment Property
2026
£
Fair Value
As at 1 February 2025 and 31 January 2026 1,778,941
5. Creditors: Amounts Falling Due Within One Year
2026
£
Other creditors 1,023,629
6. Share Capital
2026
£
Allotted, Called up and fully paid 1,000
Page 2